scholarly journals The implication of circulating long non-coding RNA MALAT1 in diagnosis, disease surveillance and prognosis of acute ischemic stroke

2019 ◽  
Author(s):  
Hongbo Ren ◽  
Feng Wu ◽  
Bin Liu ◽  
Zhi-Yuan Song ◽  
Da-Cheng Qu

Abstract Background We aimed to investigate predictive value of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (lnc-MALAT1) for acute ischemic stroke (AIS) risk, and the association of lnc-MALAT1 expression with disease severity, inflammation as well as recurrence free survival (RFS) in AIS patients.Methods 120 AIS patients and 120 controls were recruited. Venous blood samples from AIS patients (within 24 hours after symptoms onset) and controls (at entry to study) were collected to detect plasma lnc-MALAT1 expression by real-time quantitative polymerase chain reaction. For AIS patients, AIS severity was assessed by NIHSS score; plasma concentrations of inflammation factors (including C-reactive protein (CRP), tumor necrosis factor α (TNF-α), interleukin (IL)-6, IL-8, IL-10, IL-17 and IL-22) were measure; and RFS was calculated.Results Lnc-MALAT1 expression was decreased in AIS patients compared to controls, and it had a good predictive value for AIS risk (AUC=0.791, 95% CI: 0.735-0.846). For disease condition, lnc-MALAT1 expression negatively correlated with NIHSS score and pro-inflammatory factors expressions (including CRP, TNF-α, IL-6, IL-8 and IL-22), while it positively correlated with anti-inflammatory factor IL-10 expression. Besides, lnc-MALAT1 expression was elevated in AIS complicated with diabetes but numerically reduced in AIS complicated with hepertension. For prognosis, lnc-MALAT1 high expression numerically correlated with longer RFS, but without statistical significance.Conclusion lnc-MALAT1 is downregulated and has a good predictive value of AIS risk, and its high expression correlates with decreased NIHSS score, reduced inflammation, as well as numerically better RFS in AIS patients.

2021 ◽  
Vol 11 (3) ◽  
pp. 485-491
Author(s):  
Chang Jiang ◽  
Qun Yang ◽  
Bo Wang ◽  
Jun Yang ◽  
Linan Li ◽  
...  

Long non-coding RNA HOX transcript antisense RNAs (LncRNA HOTAIR) are aberrantly expressed in rheumatoid arthritis synovial fibroblasts (RASFs), the main cells in rheumatoid arthritis (RA). The inhibition, proliferation, and migrative ability of these cells offer one of the most important therapies for RA. To investigate HOTAIR in RA, 72 patients with RA were selected along with 72 healthy volunteers. Serum HOTAIR and miRNA-526b-3p levels were measured in the study groups by qRT-PCR. Following the primary isolation and culture of RASFs, HOTAIR and miRNA-526b-3p expression was detected in RASFs using qRT-PCR and the CCK-8 method was used to measure the cell proliferative capacity. The TNF-α and IL-1β levels were measured using enzyme-linked immunosorbent assay, while cell motility and invasive capacity were tested by the wound healing assay and transwell chamber assay, respectively. The dual-luciferase reporter assay measured the target-relationship of HOTAIR and miRNA-526b-3p. Western blot detected MMP-2 and MMP-13 protein levels in the samples. We show that serum HOTAIR expression levels were dramatically augmented (P < 0.05) in RA patients compared with the healthy individuals. However, the miRNA-526b-3p level was dramatically reduced (P < 0.05). Transfection of si-HOTAIR significantly reduced the OD value of RASFs, while the TNF-α level, IL-1β level, migration healing rate, MMP-2 protein expression, MMP-13 protein expression (P < 0.05), and the invasive ability were all dramatically debased (P < 0.05). HOTAIR could be a competing endogenous RNAs for miRNA-526b-3p. Inhibiting miR-526b-3p expression could dramatically reduce silent HOTAIR on multiplication, immigration, invasion, and inflammatory factor secretion of RASFs. These findings provide evidence that silent HOTAIR inhibits multiplication, immigration, invasion, and inflammatory factor secretion of RASFs by up-regulating the expression of miRNA-526b-3p.


2019 ◽  
Vol 1 (1) ◽  
pp. 11-15 ◽  
Author(s):  
Sarah Yaziz ◽  
Ahmad Sobri Muda ◽  
Wan Asyraf Wan Zaidi ◽  
Nik Azuan Nik Ismail

Background : The clot burden score (CBS) is a scoring system used in acute ischemic stroke (AIS) to predict patient outcome and guide treatment decision. However, CBS is not routinely practiced in many institutions. This study aimed to investigate the feasibility of CBS as a relevant predictor of good clinical outcome in AIS cases. Methods:  A retrospective data collection and review of AIS patients in a teaching hospital was done from June 2010 until June 2015. Patients were selected following the inclusion and exclusion criteria. These patients were followed up after 90 days of discharge. The Modified Rankin scale (mRS) was used to assess their outcome (functional status). Linear regression Spearman Rank correlation was performed between the CBS and mRS. The quality performance of the correlations was evaluated using Receiver operating characteristic (ROC) curves. Results: A total of 89 patients with AIS were analysed, 67.4% (n=60) male and 32.6% (n=29) female. Twenty-nine (29) patients (33.7%) had a CBS ?6, 6 patients (6.7%) had CBS <6, while 53 patients (59.6%) were deemed clot free. Ninety (90) days post insult, clinical assessment showed that 57 (67.6%) patients were functionally independent, 27 (30.3%) patients functionally dependent, and 5 (5.6%) patients were deceased. Data analysis reported a significant negative correlation (r= -0.611, p<0.001). ROC curves analysis showed an area under the curve of 0.81 at the cut-off point of 6.5. This showed that a CBS of more than 6 predicted a good mRS clinical outcome in AIS patients; with sensitivity of 98.2%, specificity of 53.1%, positive predictive value (PPV) of 76%, and negative predictive value (NPV) of 21%. Conclusion: CBS is a useful additional variable for the management of AIS cases, and should be incorporated into the routine radiological reporting for acute ischemic stroke (AIS) cases.


2019 ◽  
Vol 23 (3) ◽  
pp. 363-368 ◽  
Author(s):  
Bing Zhou ◽  
Xiao-Chuan Wang ◽  
Jun-Yi Xiang ◽  
Ming-Zhao Zhang ◽  
Bo Li ◽  
...  

OBJECTIVEMechanical thrombectomy using a Solitaire stent retriever has been widely applied as a safe and effective method in adult acute ischemic stroke (AIS). However, due to the lack of data, the safety and effectiveness of mechanical thrombectomy using a Solitaire stent in pediatric AIS has not yet been verified. The purpose of this study was to explore the safety and effectiveness of mechanical thrombectomy using a Solitaire stent retriever for pediatric AIS.METHODSBetween January 2012 and December 2017, 7 cases of pediatric AIS were treated via mechanical thrombectomy using a Solitaire stent retriever. The clinical practice, imaging, and follow-up results were reviewed, and the data were summarized and analyzed.RESULTSThe ages of the 7 patients ranged from 7 to 14 years with an average age of 11.1 years. The preoperative National Institutes of Health Stroke Scale (NIHSS) scores ranged from 9 to 22 with an average of 15.4 points. A Solitaire stent retriever was used in all patients, averaging 1.7 applications of thrombectomy and combined balloon dilation in 2 cases. Grade 3 on the modified Thrombolysis In Cerebral Infarction scale of recanalization was achieved in 5 cases and grade 2b in 2 cases. Six patients improved and 1 patient died after thrombectomy. The average NIHSS score of the 6 cases was 3.67 at discharge. The average modified Rankin Scale score was 1 at the 3-month follow-up. Subarachnoid hemorrhage after thrombectomy occurred in 1 case and that patient died 3 days postoperatively.CONCLUSIONSThis study shows that mechanical thrombectomy using a Solitaire stent retriever has a high recanalization rate and excellent clinical prognosis in pediatric AIS. The safety of mechanical thrombectomy in pediatric AIS requires more clinical trials for confirmation.


2021 ◽  
pp. 1-12
Author(s):  
Jang Hun Kim ◽  
Wonki Yoon ◽  
Chi Kyung Kim ◽  
Haewon Roh ◽  
Hee Jin Bae ◽  
...  

<b><i>Background:</i></b> Clinical outcome in patients with acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) is not satisfactory if reperfusion treatment fails or is not tried. <b><i>Aims:</i></b> We aimed to assess the efficacy and safety of urgent superficial temporal-to-middle cerebral artery (STA-MCA) bypass surgery in selected patients. <b><i>Methods:</i></b> Patients who were diagnosed with LVO-induced AIS in the anterior circulation but had a failed intra-arterial thrombectomy (IAT) or were not tried due to IAT contraindications were prospectively enrolled. Timely urgent STA-MCA bypass surgery was performed if they showed perfusion-diffusion mismatch or symptom-diffusion mismatch in the acute phase of disease. Clinical and radiological data of these patients were assessed to demonstrate the safety and efficacy of urgent bypass procedures. A pooled analysis of published data on urgent bypass surgery in acute stroke patients was conducted and analyzed. <b><i>Results:</i></b> In 18 patients who underwent timely bypass, the National Institutes of Health Stroke Scale (NIHSS) score improved from 12.11 ± 4.84 to 9.89 ± 6.52, 1 week after surgery. Three-month and long-term (9.72 ± 5.00 months) favorable outcomes (modified Rankin Scale [mRS] scores 0–2) were achieved in 50 and 75% of the patients, respectively. The pooled analysis (117 patients from 10 articles, including ours) identified favorable mRS scores in 71.79% patients at 3 months. A significant NIHSS score improvement from 11.51 ± 4.89 to 7.59 ± 5.50 was observed after surgery with significance. Major complications occurred in 3 patients (2.6%, 3/117) without mortality. <b><i>Conclusions:</i></b> Urgent STA-MCA bypass surgery can be regarded as a safe optional treatment to prevent cerebral infarct expansion and to improve clinical and radiological outcomes in highly selected patients.


2020 ◽  
pp. 028418512098177
Author(s):  
Yu Lin ◽  
Nannan Kang ◽  
Jianghe Kang ◽  
Shaomao Lv ◽  
Jinan Wang

Background Color-coded multiphase computed tomography angiography (mCTA) can provide time-variant blood flow information of collateral circulation for acute ischemic stroke (AIS). Purpose To compare the predictive values of color-coded mCTA, conventional mCTA, and CT perfusion (CTP) for the clinical outcomes of patients with AIS. Material and Methods Consecutive patients with anterior circulation AIS were retrospectively reviewed at our center. Baseline collateral scores of color-coded mCTA and conventional mCTA were assessed by a 6-point scale. The reliabilities between junior and senior observers were assessed by weighted Kappa coefficients. Receiver operating characteristic (ROC) curves and multivariate logistic regression model were applied to evaluate the predictive capabilities of color-coded mCTA and conventional mCTA scores, and CTP parameters (hypoperfusion and infarct core volume) for a favorable outcome of AIS. Results A total of 138 patients (including 70 cases of good outcomes) were included in our study. Patients with favorable prognoses were correlated with better collateral circulations on both color-coded and conventional mCTA, and smaller hypoperfusion and infarct core volume (all P < 0.05) on CTP. ROC curves revealed no significant difference between the predictive capability of color-coded and conventional mCTA ( P = 0.427). The predictive value of CTP parameters tended to be inferior to that of color-coded mCTA score (all P < 0.001). Both junior and senior observers had consistently excellent performances (κ = 0.89) when analyzing color-coded mCTA maps. Conclusion Color-coded mCTA provides prognostic information of patients with AIS equivalent to or better than that of conventional mCTA and CTP. Junior radiologists can reach high diagnostic accuracy when interpreting color-coded mCTA images.


Sign in / Sign up

Export Citation Format

Share Document